Augmenting anti-CD19 and anti-CD22 CAR T-cell function using PD-1-CD28 checkpoint fusion proteins.
Blaeschke F, Stenger D, Apfelbeck A, Cadilha BL, Benmebarek MR, Mahdawi J, Ortner E, Lepenies M, Habjan N, Rataj F, Willier S, Kaeuferle T, Majzner RG, Busch DH, Kobold S, Feuchtinger T.
Blaeschke F, et al. Among authors: ortner e.
Blood Cancer J. 2021 Jun 4;11(6):108. doi: 10.1038/s41408-021-00499-z.
Blood Cancer J. 2021.
PMID: 34088894
Free PMC article.
No abstract available.